2015 NEI/FDA Endpoints Workshops

Jun 26, 2015 Bethesda, Maryland

Diabetic Retinopathy

EndpointsLOGO   

Masur Auditorium – NIH Campus
Bethesda, Md.

June 26, 2015

This workshop included the newest clinical data on diabetic retinopathy and future clinical trial designs that are aimed at arresting damage from diabetes prior to significant vision loss.

This one-day public workshop reviewed clinical trial design considerations for diabetic retinopathy in order to develop strategies for:

  • Improved trial design and endpoints based on current evidence
  • Approaches to classifying and stratifying the patient population
  • Clinically meaningful surrogate or interim endpoints
  • Potentially impactful gaps for research funding

Participants discussed: 

  • Clinical trial design for progression to, and treatment of proliferative diabetic retinopathy (PDR)
  • New considerations for trial design for diabetic retinopathy edema (DME)

View the program agenda 

 
Advertisement
Eversight april 3